Case Study: a leading Canada-based pharmaceutical company achieves zero artwork recalls and cost savings with Freyr

a leading canada-based pharmaceutical company achieves zero artwork recalls and saves USD 300K+ with FREYR

A leading Canada-based pharmaceutical company faced challenges in managing its complex and decentralized artwork operations for its generic product portfolio. The company struggled with operational inefficiencies, quality risks, and a need to consolidate its fragmented outsourcing model while transitioning approximately 11,000 work-in-progress artworks. To address this, they partnered with FREYR for end-to-end artwork transition and centralized operations management.

FREYR implemented a phased transition strategy and a consolidated outsourcing model to centralize artwork execution and governance. This solution ensured operational continuity, embedded robust quality control, and streamlined workflows. As a result, FREYR achieved zero artwork recalls throughout the process and delivered over USD 300K in cost savings within the first seven months, successfully transforming the client's operations into a scalable and efficient global framework.